Scaling AAV Production: Easing the Transition from Laboratory Scales to Commercial Manufacturing
BioProcess International,
Large-scale production of adenoassociated virus (AAV) vectors at Takeda’s 1,000-L good manufacturing practice (GMP) gene…
Large-scale production of adenoassociated virus (AAV) vectors at Takeda’s 1,000-L good manufacturing practice (GMP) gene…
Mark White, PhD After decades of research, gene therapy is finally on track to deliver solutions to myriad diseases once…
Introduction Innovations in science and technology stand to transform the future of health care through the development of med-ic…
Summary Rocket Therapeutics has remained under my radar despite making headway in the gene therapy pipeline with multiple INDs…